pancreatic cancer
Conditions
Interventions
Proton therapy Alpha-Beta T-cell Therapy
Sponsors
Hyogo Ion Beam Medical Center
Seta Clinic Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Locally advanced pancreatic cancer eligible for the inclusion criteria and ineligible for the exclusion criteria of Hyogo Ion Beam Medical Center (2)Patients who can initiate immunotherapy within three months after proton therapy (3)over 20 years old (4)Performance Status is 0-2 (5)Survival more than three months (6)No serious abnormality in bone marrow, liver, and renal functions (7)Informed consent has been obtained
Exclusion criteria
Exclusion criteria: (1)Interstitial pneumonia (2)Active autoimmune disease (3)Active heart trouble (4)uncontrolable infectious diseases. (5)Serious drug allergy (6)Continuous systemic administration of steroids (7)Pregnancy (8)Positive for HIV or HTLV-1 (9)patients who are inadequate to enter this study due to the other reasons by physician's judgments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| distant disease-free rate | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival survival rate local control rate frequency and type of adverse events QOL immunological parameters | — |
Countries
Japan
Contacts
Public ContactKazuki Terashima
Hyogo Ion Beam Medical Center Department of Radiology
Outcome results
None listed